These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34929561)

  • 21. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of serum galectin-3 level with renal volume and function in adult polycystic kidney disease.
    Ozkurt S; Dogan I; Ozcan O; Fidan N; Bozaci I; Yilmaz B; Bilgin M
    Int Urol Nephrol; 2019 Jul; 51(7):1191-1197. PubMed ID: 31012038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of acute kidney injury after revascularization on the development of chronic kidney disease and mortality in patients with chronic limb ischemia.
    Arora P; Davari-Farid S; Pourafkari L; Gupta A; Dosluoglu HH; Nader ND
    J Vasc Surg; 2015 Mar; 61(3):720-7. PubMed ID: 25499712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perioperative and long-term impact of chronic kidney disease on carotid artery interventions.
    Klarin D; Lancaster RT; Ergul E; Bertges D; Goodney P; Schermerhorn ML; Cambria RP; Patel VI;
    J Vasc Surg; 2016 Nov; 64(5):1295-1302. PubMed ID: 27776697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galectin-3 binding protein plasma levels are associated with long-term mortality in coronary artery disease independent of plaque morphology.
    Gleissner CA; Erbel C; Linden F; Domschke G; Akhavanpoor M; Doesch AO; Buss SJ; Giannitsis E; Katus HA; Korosoglou G
    Atherosclerosis; 2016 Aug; 251():94-100. PubMed ID: 27295060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galectin-1 and Galectin-3 Expression in Lesional Skin of Patients With Systemic Sclerosis-Association With Disease Severity.
    Mora GF; Zubieta MR
    J Clin Rheumatol; 2021 Dec; 27(8):317-323. PubMed ID: 32501939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of chronic kidney disease on lower extremity bypass outcomes in patients with critical limb ischemia.
    Ambur V; Park P; Gaughan JP; Golarz S; Schmieder F; Van Bemmelen P; Choi E; Dhanisetty R
    J Vasc Surg; 2019 Feb; 69(2):491-496. PubMed ID: 30154013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiopoietin-2 and Survival in Peripheral Artery Disease Patients.
    Höbaus C; Pesau G; Herz CT; Wrba T; Koppensteiner R; Schernthaner GH
    Thromb Haemost; 2018 Apr; 118(4):791-797. PubMed ID: 29618157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between kidney disease and endothelial function in peripheral artery disease.
    Chong KC; Owens CD; Park M; Alley HF; Boscardin WJ; Conte MS; Gasper WJ; Grenon SM
    J Vasc Surg; 2014 Dec; 60(6):1605-11. PubMed ID: 25441679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma galectin-3 is associated with decreased glomerular filtration rate in chronic HIV.
    Vares-Lum DL; Gangcuangco LMA; Park J; Manzano E; Ortega M; Chow DC; Shikuma C
    HIV Res Clin Pract; 2023 Sep; 24(1):2261753. PubMed ID: 37783570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal tubular damage is associated with poor clinical outcome in patients with peripheral artery disease who underwent endovascular therapy.
    Otaki Y; Watanabe T; Takahashi H; Yamaura G; Nishiyama S; Arimoto T; Shishido T; Miyamoto T; Kubota I
    Int J Cardiol; 2016 Oct; 220():376-81. PubMed ID: 27390958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Correlates and Prognostic Value of Plasma Galectin-3 Levels in Degenerative Aortic Stenosis: A Single-Center Prospective Study of Patients Referred for Invasive Treatment.
    Bobrowska B; Wieczorek-Surdacka E; Kruszelnicka O; Chyrchel B; Surdacki A; Dudek D
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28468272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the role of galectin 3 in kidney function: a genetic approach.
    Bichara M; Attmane-Elakeb A; Brown D; Essig M; Karim Z; Muffat-Joly M; Micheli L; Eude-Le Parco I; Cluzeaud F; Peuchmaur M; Bonvalet JP; Poirier F; Farman N
    Glycobiology; 2006 Jan; 16(1):36-45. PubMed ID: 16166603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating Galectin-3 Following Heart Transplant: Long-term Dynamics and Prognostic Value.
    Suárez-Fuentetaja N; Barge-Caballero E; Bayés-Genís A; Doménech N; Moreda-Santamaría L; Paniagua-Martín MJ; Barge-Caballero G; Couto-Mallón D; Solla-Buceta M; Estévez-Cid F; Cuenca-Castillo JJ; Pombo-Otero J; Grille-Cancela Z; Blanco-Canosa P; Muñiz J; Vázquez-Rodríguez JM; Crespo-Leiro MG
    Rev Esp Cardiol (Engl Ed); 2019 Nov; 72(11):899-906. PubMed ID: 30477951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of sCD163 and sTWEAK in patients with stable peripheral arterial disease and association with disease severity as well as long-term mortality.
    Mrak D; Zierfuss B; Höbaus C; Herz CT; Pesau G; Schernthaner GH
    Atherosclerosis; 2021 Jan; 317():41-46. PubMed ID: 33378730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary fatty acid binding protein 3 (uFABP3) is a potential biomarker for peripheral arterial disease.
    Zamzam A; Syed MH; Harlock J; Eikelboom J; Singh KK; Abdin R; Qadura M
    Sci Rep; 2021 May; 11(1):11061. PubMed ID: 34040076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure.
    Lok DJ; Lok SI; Bruggink-André de la Porte PW; Badings E; Lipsic E; van Wijngaarden J; de Boer RA; van Veldhuisen DJ; van der Meer P
    Clin Res Cardiol; 2013 Feb; 102(2):103-10. PubMed ID: 22886030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary calciprotein particle size is associated with patient mortality in peripheral artery disease.
    Bojic M; Cejka D; Bielesz B; Schernthaner GH; Höbaus C
    Atherosclerosis; 2023 Apr; 370():12-17. PubMed ID: 36898866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.